Page last updated: 2024-08-16
sb 202190 and genipin
sb 202190 has been researched along with genipin in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Feng, Y; Man, K; Tsao, SW; Wang, N; Zhang, Z; Zhu, M | 1 |
Other Studies
1 other study(ies) available for sb 202190 and genipin
| Article | Year |
|---|---|
Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cholagogues and Choleretics; Down-Regulation; Gene Silencing; Humans; Imidazoles; Iridoids; Liver Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Second Primary; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Up-Regulation | 2012 |